<DOC>
	<DOCNO>NCT00002154</DOCNO>
	<brief_summary>The purpose study see safe effective give thioctic acid deprenyl ( selegiline hydrochloride ) , alone combination , HIV-infected patient mild moderate dementia ( decline mental ability ) .</brief_summary>
	<brief_title>A Study Thioctic Acid Deprenyl HIV-Infected Patients With Dementia</brief_title>
	<detailed_description>Patients randomize receive thioctic acid alone , deprenyl alone , thioctic acid/deprenyl , placebo alone 10 week , patient may receive active drug open-label basis . Patients must seven clinic visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<mesh_term>Selegiline</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretrovirals provide dose stable least 6 week prior study entry . Patients must : HIV seropositivity . Mild moderate cognitive impairment ( problem short term memory , concentration , feel slow ) . No active opportunistic CNS infection . Ability give inform consent . Prior Medication : Allowed : Prior antiretrovirals provide dose stable least past 6 week . Prior thioctic acid deprenyl . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Severe premorbid psychiatric illness include schizophrenia major depression would interfere study compliance . CNS neoplasms . Any clinically significant condition laboratory abnormality would preclude participation study . Current participation drug study . Concurrent Medication : Excluded : Chemotherapy malignancy . Patients follow prior condition exclude : History chronic neurological disorder serious head injury , document stroke , multiple sclerosis , uncontrolled epilepsy , Tourette 's syndrome , neurodegenerative process Huntington 's disease . Prior participation study . History adverse reaction/allergy thioctic acid deprenyl . Prior Medication : Excluded : Other investigational drug within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Cognition Disorders</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Thioctic Acid</keyword>
	<keyword>Selegiline</keyword>
</DOC>